COMMUNIQUÉS West-GlobeNewswire

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
16/04/2026
SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will share six abstracts, including two podium [...]
Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan
16/04/2026
First-of-its-kind plan expands access to comprehensive, outcomes-based family building and women’s health care with predictable costs for small U.S. employers NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. ( [...]
ENvue Issues Stockholder Letter & Provides Corporate Update
16/04/2026
TYLER, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive [...]
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
16/04/2026
-- Partnership with AMI Technologies Positions FemaSeed ® as a First-Line Infertility Treatment in Israel, Expanding Market Access to Innovative Fertility Solutions -- ATLANTA, April 16, 2026 (GLOBE NEWSWIRE) -- Femasys [...]
Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications
16/04/2026
April 16, 2026 Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical insight across radiology, cardiology, and oncology Amsterdam, the [...]
Nearly 4 in 10 women are missing vaginal bacteria linked to fertility
16/04/2026
Analysis by Tiny Health found that 39% of women sampling their vaginal microbiome had low or absent Lactobacillus levels, and nearly half had at least one microbiome imbalance associated with fertility concerns AUSTIN, [...]
AIM ImmunoTech Enters Pivotal Value Inflection Phase with Planned Phase 3 Study of Ampligen® in Pancreatic Cancer, Backed by Positive Clinical Signals, Orphan Drug Status, and Global IP
16/04/2026
Company to participate in Live Virtual Investor Closing Bell segment today, April 16 th  at 4:00 PM ET ; Register for the event here OCALA, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: [...]
Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors
16/04/2026
Achieve Names Two New Exemplary Healthcare Leaders to its Board of Directors New Leadership and Financing, up to $354 Million ($180 Million Upfront and $174 Million Dependent on the Exercise of Milestone Warrants), [...]
Achieve Life Sciences Announces Up to $354 Million Private Placement
16/04/2026
$180 Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations, venBio Partners, [...]
Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026
16/04/2026
Poster presentation scheduled for Tuesday, May 5th at 12:30 PM CDT Denver, CO, April 16, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical [...]
Blood Cancer Patients and Their Supporters Cycle Across Iceland to Raise Funds and Awareness for Multiple Myeloma and the International Myeloma Foundation’s Research
16/04/2026
3rd Annual Iceland Cycling Expedition from August 18-24, 2026, Aims to Fund Myeloma Prevention and a Cure STUDIO CITY, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today [...]
Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
16/04/2026
TORONTO, April 16, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, [...]
Nanox.ARC X Digital Advanced 3D imaging built for access and powered by innovation Wins 2026 Red Dot Award for Product Design
16/04/2026
International Red Dot Jury recognizes Nanox.ARC X for design excellence that brings advanced 3D tomosynthesis imaging into a wider range of clinical settings PETACH TIKVA, ISRAEL - 1 6 April , 2026 - Nanox Imaging Ltd [...]
SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc.
16/04/2026
SRXH files Form S-4 with SEC in connection with EMJX merger SRXH provides update on performance through mid-April with an approximate 3.5% gain in hedging pool, driven by EMJX’s algorithm, and an approximate gain of 8% [...]
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
16/04/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today provides a strategic update outlining its positioning as a multi-pathway value [...]
Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress
16/04/2026
AGOURA HILLS, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We”), a clinical-stage biopharmaceutical company developing drugs for the treatment of [...]
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway
16/04/2026
Company and Laboratory Partner Believe Properly Documented Claims Are Positioned for Payment Under Existing $300 CMS Reimbursement Rate The Medicare Administrative Contractor (MAC) responsible for processing inFoods® [...]
Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026
16/04/2026
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX) (“Ardelyx” or the “Company”), a commercial-stage biopharmaceutical company focused on [...]
Helsinn appoints Giacomo Braglia to the Board of Directors
16/04/2026
Lugano, Switzerland – April 16 th , 2026 – Helsinn Healthcare SA (“Helsinn”), a global pharmaceutical group focused on supporting patients with cancer and chronic diseases, is pleased to announce the appointment of [...]

Pages